125 related articles for article (PubMed ID: 19016758)
1. Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance.
Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2008 Oct; 99(10):1984-91. PubMed ID: 19016758
[TBL] [Abstract][Full Text] [Related]
2. Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance.
Ghosh A; Ghosh S; Maiti GP; Sabbir MG; Zabarovsky ER; Roy A; Roychoudhury S; Panda CK
Cancer Sci; 2010 Jun; 101(6):1511-20. PubMed ID: 20412120
[TBL] [Abstract][Full Text] [Related]
3. RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance.
Mitra S; Mazumder Indra D; Bhattacharya N; Singh RK; Basu PS; Mondal RK; Roy A; Zabarovsky ER; Roychoudhury S; Panda CK
Genes Chromosomes Cancer; 2010 Feb; 49(2):155-70. PubMed ID: 19885927
[TBL] [Abstract][Full Text] [Related]
4. Alterations in candidate genes PHF2, FANCC, PTCH1 and XPA at chromosomal 9q22.3 region: pathological significance in early- and late-onset breast carcinoma.
Sinha S; Singh RK; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Cancer; 2008 Nov; 7():84. PubMed ID: 18990233
[TBL] [Abstract][Full Text] [Related]
5. RBSP3 (HYA22) is a tumor suppressor gene implicated in major epithelial malignancies.
Kashuba VI; Li J; Wang F; Senchenko VN; Protopopov A; Malyukova A; Kutsenko AS; Kadyrova E; Zabarovska VI; Muravenko OV; Zelenin AV; Kisselev LL; Kuzmin I; Minna JD; Winberg G; Ernberg I; Braga E; Lerman MI; Klein G; Zabarovsky ER
Proc Natl Acad Sci U S A; 2004 Apr; 101(14):4906-11. PubMed ID: 15051889
[TBL] [Abstract][Full Text] [Related]
6. Frequent alterations of LOH11CR2A, PIG8 and CHEK1 genes at chromosomal 11q24.1-24.2 region in breast carcinoma: clinical and prognostic implications.
Sinha S; Singh RK; Bhattacharya N; Mukherjee N; Ghosh S; Alam N; Roy A; Roychoudhury S; Panda CK
Mol Oncol; 2011 Oct; 5(5):454-64. PubMed ID: 21803008
[TBL] [Abstract][Full Text] [Related]
7. Analysis of different deleted regions in chromosome 11 and their interrelations in early- and late-onset breast tumors: association with cyclin D1 amplification and survival.
Chunder N; Mandal S; Roy A; Roychoudhury S; Panda CK
Diagn Mol Pathol; 2004 Sep; 13(3):172-82. PubMed ID: 15322430
[TBL] [Abstract][Full Text] [Related]
8. Protein expression and methylation of DNA repair genes hMLH1, hMSH2, MGMT and BRCA1 and their correlation with clinicopathological parameters and prognosis in basal-like breast cancer.
Alkam Y; Mitomi H; Nakai K; Himuro T; Saito T; Takahashi M; Arakawa A; Yao T; Saito M
Histopathology; 2013 Nov; 63(5):713-25. PubMed ID: 24004112
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of epigenetic inactivation of hMLH1 and BRCA1 in Tunisian patients with invasive breast carcinoma.
Karray-Chouayekh S; Trifa F; Khabir A; Boujelbane N; Sellami-Boudawara T; Daoud J; Frikha M; Gargouri A; Mokdad-Gargouri R
J Biomed Biotechnol; 2009; 2009():369129. PubMed ID: 19644562
[TBL] [Abstract][Full Text] [Related]
10. Promoter methylation status of hMLH1, hMSH2, and MGMT genes in colorectal cancer associated with adenoma-carcinoma sequence.
Lee KH; Lee JS; Nam JH; Choi C; Lee MC; Park CS; Juhng SW; Lee JH
Langenbecks Arch Surg; 2011 Oct; 396(7):1017-26. PubMed ID: 21706233
[TBL] [Abstract][Full Text] [Related]
11. [Down-regulation of RBSP3/CTDSPL, NPRL2/G21, RASSF1A, ITGA9, HYAL1 and HYAL2 genes in non-small cell lung cancer].
Anedchenko EA; Dmitriev AA; Krasnov GS; Kondrat'eva TT; Kopantsev EP; Vinogradova TV; Zinov'eva MV; Zborovskaia IB; Polotskiĭ BE; Sakharova OV; Kashuba VI; Zabarovskiĭ ER; Senchenko VN
Mol Biol (Mosk); 2008; 42(6):965-76. PubMed ID: 19140316
[TBL] [Abstract][Full Text] [Related]
12. Expression of the hMLH1 gene is a possible predictor for the clinical response to 5-fluorouracil after a surgical resection in colorectal cancer.
Ide T; Kitajima Y; Ohtaka K; Mitsuno M; Nakafusa Y; Miyazaki K
Oncol Rep; 2008 Jun; 19(6):1571-6. PubMed ID: 18497967
[TBL] [Abstract][Full Text] [Related]
13. Expression and promoter methylation status of mismatch repair gene hMLH1 and hMSH2 in epithelial ovarian cancer.
Zhang H; Zhang S; Cui J; Zhang A; Shen L; Yu H
Aust N Z J Obstet Gynaecol; 2008 Oct; 48(5):505-9. PubMed ID: 19032668
[TBL] [Abstract][Full Text] [Related]
14. Novel tumor suppressor candidates on chromosome 3 revealed by NotI-microarrays in cervical cancer.
Senchenko VN; Kisseljova NP; Ivanova TA; Dmitriev AA; Krasnov GS; Kudryavtseva AV; Panasenko GV; Tsitrin EB; Lerman MI; Kisseljov FL; Kashuba VI; Zabarovsky ER
Epigenetics; 2013 Apr; 8(4):409-20. PubMed ID: 23478628
[TBL] [Abstract][Full Text] [Related]
15. Methylation of the 3p22 region encompassing MLH1 is representative of the CpG island methylator phenotype in colorectal cancer.
Wong JJ; Hawkins NJ; Ward RL; Hitchins MP
Mod Pathol; 2011 Mar; 24(3):396-411. PubMed ID: 21102416
[TBL] [Abstract][Full Text] [Related]
16. [Aberrant methylation of hMLH1 gene promoter in papillary thyroid cancer and its clinical significance].
Lu XX; Ge MH; Ling ZQ; Hu SS; Xu J; Zheng CM; Tan Z; Chen C
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):833-6. PubMed ID: 24447481
[TBL] [Abstract][Full Text] [Related]
17. Significance of mismatch repair protein expression in the chemotherapeutic response of sporadic invasive ductal carcinoma of the breast.
Son BH; Ahn SH; Ko CD; Ka IW; Gong GY; Kim JC
Breast J; 2004; 10(1):20-6. PubMed ID: 14717755
[TBL] [Abstract][Full Text] [Related]
18. Hypermethylation analysis of mismatch repair genes (hmlh1 and hmsh2) in locally advanced breast cancers in Indian women.
Naqvi RA; Hussain A; Deo SS; Kukreti H; Chauhan M; Sarin R; Saxena A; Asim M; Shukla NK; Husain SA; Pasha ST; Basir SF
Hum Pathol; 2008 May; 39(5):672-80. PubMed ID: 18329696
[TBL] [Abstract][Full Text] [Related]
19. [Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].
Fu Q; Yao GY; Tang XL; Chen LR; Zheng ZX
Zhonghua Zhong Liu Za Zhi; 2007 Jan; 29(1):34-40. PubMed ID: 17575691
[TBL] [Abstract][Full Text] [Related]
20. The high frequency of de novo promoter methylation in synchronous primary endometrial and ovarian carcinomas.
Furlan D; Carnevali I; Marcomini B; Cerutti R; Dainese E; Capella C; Riva C
Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3329-36. PubMed ID: 16740754
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
